163 related articles for article (PubMed ID: 10597280)
1. The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells.
Shang Y; Baumrucker CR; Green MH
Oncogene; 1999 Nov; 18(48):6725-32. PubMed ID: 10597280
[TBL] [Abstract][Full Text] [Related]
2. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
3. The DNA-binding epidermal growth factor-receptor inhibitor PD153035 and other DNA-intercalating cytotoxic drugs reactivate the expression of the retinoic acid receptor-beta tumor-suppressor gene in breast cancer cells.
Grunt TW; Tomek K; Wagner R; Puckmair K; Zielinski CC
Differentiation; 2007 Nov; 75(9):883-90. PubMed ID: 17608728
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
[TBL] [Abstract][Full Text] [Related]
5. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
Dietze EC; Caldwell LE; Marcom K; Collins SJ; Yee L; Swisshelm K; Hobbs KB; Bean GR; Seewaldt VL
Microsc Res Tech; 2002 Oct; 59(1):23-40. PubMed ID: 12242694
[TBL] [Abstract][Full Text] [Related]
6. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
Johnson MR; Valentine C; Basilico C; Mansukhani A
Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
[TBL] [Abstract][Full Text] [Related]
7. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
8. Effects of retinoic acid and gamma-interferon on expression of retinoic acid receptor and cellular retinoic acid-binding protein in breast cancer cells.
Widschwendter M; Daxenbichler G; Dapunt O; Marth C
Cancer Res; 1995 May; 55(10):2135-9. PubMed ID: 7743514
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
Gooch JL; Herrera RE; Yee D
Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
12. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
[TBL] [Abstract][Full Text] [Related]
13. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
Lehmann S; Paul C; Törmä H
Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
[TBL] [Abstract][Full Text] [Related]
14. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
15. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
16. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
Fanjul AN; Bouterfa H; Dawson M; Pfahl M
Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
[TBL] [Abstract][Full Text] [Related]
17. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth.
Li XS; Shao ZM; Sheikh MS; Eiseman JL; Sentz D; Jetten AM; Chen JC; Dawson MI; Aisner S; Rishi AK
J Cell Physiol; 1995 Dec; 165(3):449-58. PubMed ID: 7593223
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid activates caspase-1 in a dose-dependent manner in cervical squamous carcinoma cells.
Arany I; Ember IA; Tyring SK
Anticancer Res; 2003; 23(1A):471-3. PubMed ID: 12680251
[TBL] [Abstract][Full Text] [Related]
20. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
